Beta-2 microglobulin as a predictor of peripheral arterial disease in diabetes : the effect of estimated glomerular filtration
Loading...
Date
Authors
Rheeder, Paul
Nel, L.
Meeuws, F.
Van Schendel, M.
Meyer, Pieter Willem Adriaan
Journal Title
Journal ISSN
Volume Title
Publisher
Medpharm Publications
Abstract
BACKGROUND: Peripheral arterial disease (PAD) is common in patients with type 2 diabetes mellitus. Its definitive
diagnosis requires ultrasound or angiography. Beta-2 microglobulin (β2 microglobulin) has been proposed as a
diagnostic marker for PAD. The objective of the study was to evaluate the diagnostic value of β2 microglobulin for
PAD in patients with diabetes and varying renal function.
DESIGN: This was a cross-sectional study.
SETTING: An academic centre (University of Pretoria and Steve Biko Academic Hospital Diabetes Clinic).
SUBJECTS: One hundred and eight convenience-sampled patients.
OUTCOME MEASURES: Patients completed a questionnaire and had toe and arm blood pressure (toe-arm index), as
well as serum β2 microglobulin and creatinine, measured.
RESULTS: Beta-2 microglobulin did not differ (p-value = 0.34) between those subjects with PAD (n = 43) and those
without PAD (n = 65). In a linear regression model, the interaction term between estimated glomerular filtration rate
categories and the inverse of β2 microglobulin was highly significant (p-value = 0.001).
CONCLUSION: Although the sample size was small, β2 microglobulin did not distinguish between subjects with and
without PAD. Renal function and its effects on the association between β2 microglobulin and PAD need further
study.
Description
Keywords
Peripheral arterial disease, Diabetes, Mellitus, β2 microglobulin
Sustainable Development Goals
Citation
Rheeder, P, Nel. L, Meeuws, F., Van Schendel, M & Meyer, PWA 2012, 'Beta-2 microglobulin as a predictor of peripheral arterial disease in diabetes : the effect of estimated glomerular filtration', Journal of Endocrinology, Metabolism & Diabetes of South Africa, vol. 17, no. 3, pp. 141-144.